This publication highlights ongoing challenges in drug policy at European and global levels and provides insight into how civil society can assist policy makers and legislators in tackling these issues.
This publication provides Western Australia's Select Committee's suggestions into alternate approaches to reducing illicit drug use and its effects on the community.
This paper is the first to measure the prevalence of HIV, HBV, and HCV in Mozambique and to assess demographic characteristics and risk behaviours in this population.
The Beckley Foundation analyses issues surrounding MDMA in details: from its production to consumption, its risks and harms, and the impact of restriction policies.
Despite much speculation and conjecture over potential crossovers between terrorists and the drug trade in Europe, no study has examined the issue. This paper fills this gap by empirically examining such crossovers in the European Union between 2012 and 2017.
This paper outlines the position of the International Network of People who Use Drugs (INPUD), developed after extensive research and in consultation with people who use drugs and their allies, on prolonged-release buprenorphine formulations.
The Canadian Centre on Substance Abuse provides a preliminary synthesis of the country’s experience with cannabis legalisation in the first year of retail sales.
The UK House of Commons Scottish Affairs Committee calls for an overhaul to the governmental response to drug-related challenges, including significant investment towards harm reduction and the decriminalisation of people who use drugs.
